Assembly Biosciences, Inc. (ASMB) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 381.28M |
| Enterprise Value | 325.46M |
| P/E Ratio | -42.48 |
| PEG Ratio | -0.2 |
| Price/Sales Ratio | 5.51 |
| Price/Book Ratio | 2.1 |
| Enterprise/Revenue | 5.11 |
| Enterprise/EBITDA | -57.98 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.09 |
| Operating Margin | -0.19 |
| Return On Assets | -0.03 |
| Return On Equity | -0.04 |
| Revenue | 72.3M |
| Revenue/Share | 4.21 |
| Gross Profit | 72.17M |
| EBITDA | -5.99M |
| Net Income | -6.12M |
| Diluted EPS | -0.55 |
| Total Cash | 226.6M |
| Total Cash/Share | 13.41 |
| Total Debt | 2.49M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 6.65 |
| Book Value Per Share | 11.75 |
| 52-Week Change | 44.1 |
| 52-Week High | 39.71 |
| 52-Week Low | 16.8 |
| Moving Average 50 Days | 27.18 |
| Moving Average 200 Days | 28.88 |
| Average Volume | 149,211 |
| Shares Outstanding | 15.89M |
| % Held by Institutions | 121.03 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
| Last Split Date | February 12, 2024 |